MW1174A1 - Cephalosporin sulfonate esters - Google Patents
Cephalosporin sulfonate estersInfo
- Publication number
- MW1174A1 MW1174A1 MW11/74*UA MW1174A MW1174A1 MW 1174 A1 MW1174 A1 MW 1174A1 MW 1174 A MW1174 A MW 1174A MW 1174 A1 MW1174 A1 MW 1174A1
- Authority
- MW
- MALAWI
- Prior art keywords
- cephalosporin
- sulfonate esters
- sulfonate
- esters
- cephalosporin sulfonate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/439,207 US3985737A (en) | 1974-02-06 | 1974-02-06 | 3-Sulfonate esters of cephalosporin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MW1174A1 true MW1174A1 (en) | 1975-05-13 |
Family
ID=23743737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MW11/74*UA MW1174A1 (en) | 1974-02-06 | 1974-03-20 | Cephalosporin sulfonate esters |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US3985737A ( ) |
| JP (1) | JPS6123198B2 ( ) |
| AR (1) | AR207327A1 ( ) |
| AT (1) | AT329182B ( ) |
| BE (1) | BE813170A ( ) |
| BG (1) | BG25998A3 ( ) |
| BR (1) | BR7404086A ( ) |
| CA (1) | CA1019322A ( ) |
| CH (1) | CH596224A5 ( ) |
| CS (1) | CS185638B2 ( ) |
| DD (1) | DD117466A5 ( ) |
| DE (1) | DE2417987A1 ( ) |
| DK (1) | DK119974A ( ) |
| EG (1) | EG11160A ( ) |
| ES (1) | ES427236A1 ( ) |
| FI (1) | FI60213C ( ) |
| FR (1) | FR2269926B1 ( ) |
| GB (1) | GB1457668A ( ) |
| GT (1) | GT197432531A ( ) |
| HU (1) | HU170811B ( ) |
| IE (1) | IE39068B1 ( ) |
| IL (1) | IL44360A ( ) |
| IN (1) | IN139919B ( ) |
| MW (1) | MW1174A1 ( ) |
| NL (1) | NL7403127A ( ) |
| NO (2) | NO741092L ( ) |
| OA (1) | OA04642A ( ) |
| PH (1) | PH11197A ( ) |
| PL (1) | PL90985B1 ( ) |
| RO (1) | RO63020A ( ) |
| SE (1) | SE414769B ( ) |
| SU (1) | SU576946A3 ( ) |
| YU (1) | YU35891B ( ) |
| ZA (1) | ZA741424B ( ) |
| ZM (1) | ZM5574A1 ( ) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0645625B2 (ja) * | 1984-12-28 | 1994-06-15 | 塩野義製薬株式会社 | ヒドロキシセフアムカルボン酸エステルの製造法 |
| US5245027A (en) * | 1989-11-21 | 1993-09-14 | Bristol-Myers Squibb Company | 3-fluorosulfonyloxyceph-3-em compounds |
| US5043439A (en) * | 1990-03-08 | 1991-08-27 | Bristol-Myers Squibb Company | Process for production of cephalosporins |
| AR035728A1 (es) * | 2001-01-16 | 2004-07-07 | Merck & Co Inc | Proceso perfeccionado para la sintesis de carbapenem |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1241657A (en) * | 1967-08-21 | 1971-08-04 | Glaxo Lab Ltd | Improvements in or relating to cephalosporin compounds |
-
1974
- 1974-01-01 AR AR253174A patent/AR207327A1/es active
- 1974-02-06 US US05/439,207 patent/US3985737A/en not_active Expired - Lifetime
- 1974-03-05 ZA ZA00741424A patent/ZA741424B/xx unknown
- 1974-03-06 DK DK119974A patent/DK119974A/da not_active Application Discontinuation
- 1974-03-06 IL IL44360A patent/IL44360A/en unknown
- 1974-03-06 PH PH15587A patent/PH11197A/en unknown
- 1974-03-07 NL NL7403127A patent/NL7403127A/xx not_active Application Discontinuation
- 1974-03-07 IE IE483/74A patent/IE39068B1/xx unknown
- 1974-03-07 GB GB1035174A patent/GB1457668A/en not_active Expired
- 1974-03-07 HU HU74EI00000531A patent/HU170811B/hu unknown
- 1974-03-11 YU YU632/74A patent/YU35891B/xx unknown
- 1974-03-12 SE SE7403306A patent/SE414769B/xx not_active IP Right Cessation
- 1974-03-13 CA CA194,880A patent/CA1019322A/en not_active Expired
- 1974-03-19 ZM ZM55/74A patent/ZM5574A1/xx unknown
- 1974-03-20 RO RO7400078103A patent/RO63020A/ro unknown
- 1974-03-20 MW MW11/74*UA patent/MW1174A1/xx unknown
- 1974-03-21 SU SU7402011081A patent/SU576946A3/ru active
- 1974-03-25 CS CS7400002153A patent/CS185638B2/cs unknown
- 1974-03-27 NO NO741092A patent/NO741092L/no unknown
- 1974-03-29 FR FR7411525A patent/FR2269926B1/fr not_active Expired
- 1974-04-01 FI FI993/74A patent/FI60213C/fi active
- 1974-04-02 BE BE1005849A patent/BE813170A/xx not_active IP Right Cessation
- 1974-04-03 GT GT197432531A patent/GT197432531A/es unknown
- 1974-04-10 PL PL1974170245A patent/PL90985B1/pl unknown
- 1974-04-11 DE DE19742417987 patent/DE2417987A1/de not_active Withdrawn
- 1974-04-16 AT AT312274A patent/AT329182B/de not_active IP Right Cessation
- 1974-04-16 IN IN854/CAL/74A patent/IN139919B/en unknown
- 1974-04-17 DD DD177966A patent/DD117466A5/xx unknown
- 1974-04-17 OA OA55182A patent/OA04642A/xx unknown
- 1974-04-25 BG BG7426511A patent/BG25998A3/xx unknown
- 1974-04-25 JP JP49047460A patent/JPS6123198B2/ja not_active Expired
- 1974-05-13 EG EG168/74A patent/EG11160A/xx active
- 1974-05-20 BR BR4086/74A patent/BR7404086A/pt unknown
- 1974-05-22 CH CH704474A patent/CH596224A5/xx not_active IP Right Cessation
- 1974-06-12 ES ES427236A patent/ES427236A1/es not_active Expired
-
1979
- 1979-08-13 NO NO792632A patent/NO792632L/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL48341A0 (en) | 3-thio-substituted cephalosporin antibiotics | |
| GB1539518A (en) | Cephalosporin compounds | |
| GB1484395A (en) | Substituted phenoxy-thiobenzoic acid esters | |
| IE41406L (en) | 7-aminocephalosporanic acids | |
| GB1542051A (en) | Cephalosporin esters | |
| GB1537844A (en) | Cephalosporin compounds | |
| IL47802A0 (en) | Novel cephalosporin compounds | |
| IE40636L (en) | N-bromoalkylazetidinones; cephalosporin intermediates | |
| GB1487658A (en) | Cephalosporin derivative | |
| HK45081A (en) | Tetrazolethiomethyl cephalosporin compounds | |
| ZA755654B (en) | N-acylamino-alpha-arylacetamido cephalosporins | |
| IE41150L (en) | Cephalosporin derivatives | |
| ZA741424B (en) | Cephalosporin sulfonate esters | |
| PH11072A (en) | Cephalosporin antibiotics | |
| IL47113A0 (en) | Cephalosporin esters | |
| FR2283141A1 (fr) | Esters de cephalosporine | |
| PH11815A (en) | Cephalosporin esters | |
| AU8451975A (en) | 3-heterothio-7-ureido cephalosporins | |
| AU469786B2 (en) | Dimethytin esters | |
| IL47933A0 (en) | Preparation of cephalosporin esters | |
| AU479465B2 (en) | Cephalosporin sulfonate esters | |
| AU8187175A (en) | New 2-phenylalkyl esters | |
| ZA753621B (en) | Penicillins | |
| GB1486272A (en) | Cephalosporins | |
| GB1484616A (en) | Tetrazolymethylthioacetyl cephalosporin derivatives |